Answer
Yescarta (axicabtagene ciloleucel) is not recommended during pregnancy because transduced cells, if they cross the placenta, may cause foetal toxicity, including B-cell lymphocytopenia; pregnant women must be advised of potential foetal risks.
Sources for this answer
- YESCARTAGilead Sciences Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 19Document updated
Sources checked